Neuraxis financials
$7.80+5.41%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9M | $1.6M | $968.1K | $811.4K | $894.1K | $895.7K | $761.2K | $666.6K | $611.5K | $646.6K | $531.5K | $477.5K |
| Gross profit | $1.7M | $1.4M | $826.5K | $675.9K | $747.4K | $756.2K | $656.1K | $569.6K | $538.0K | $571.6K | $459.1K | $410.2K |
| Gross margin | 85.9% | 86.4% | 85.4% | 83.3% | 83.6% | 84.4% | 86.2% | 85.4% | 88.0% | 88.4% | 86.4% | 85.9% |
| Operating income | -$2.1M | -$1.7M | -$1.7M | -$2.1M | -$1.7M | -$2.3M | -$1.5M | -$1.7M | -$2.2M | -$1.8M | -$1.6M | -$3.0M |
| Net income | -$2.3M | -$2.0M | -$1.9M | -$2.3M | -$1.9M | -$2.5M | -$1.6M | -$1.8M | -$2.9M | -$2.1M | -$1.6M | -$8.6M |
| Net margin | −118.1% | −121.3% | −196.6% | −286.1% | −212.3% | −278.3% | −212.1% | −270.0% | −477.1% | −328.0% | −299.6% | −1806.5% |
| Diluted EPS | $-0.19 | $-0.18 | $-0.18 | $-0.24 | $-0.22 | $-0.33 | $-0.23 | $-0.25 | $-0.42 | $-0.32 | $-0.30 | $-2.38 |
| EBITDA | -$2.1M | -$1.7M | -$1.7M | -$2.1M | -$1.7M | -$2.3M | -$1.5M | -$1.6M | -$2.2M | -$1.8M | -$1.6M | -$3.0M |
| Operating cash flow | -$1.0M | -$1.2M | -$1.9M | -$1.4M | -$1.5M | -$1.6M | -$1.8M | -$1.4M | -$1.6M | -$1.3M | -$2.6M | -$2.8M |
| Free cash flow | -$1.0M | -$1.2M | -$1.9M | -$1.4M | -$1.5M | -$1.6M | -$1.8M | -$1.4M | -$1.6M | -$1.3M | -$2.6M | -$2.8M |
| Diluted shares | 12.1M | 10.9M | 10.5M | 9.9M | 8.5M | 7.5M | 7.0M | 7.2M | 6.9M | 6.6M | 5.4M | 3.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.3M | $7.1M | $5.0M | $4.4M | $6.0M | $2.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $42.7K | $100.7K | $148.3K | $195.7K | $121.4K | $84.3K |
| Total assets | $10.0M | $8.7M | $6.4M | $5.8M | $7.1M | $3.0M |
| Total liabilities | $3.3M | $3.0M | $3.0M | $3.5M | $2.8M | $2.8M |
| Shareholders' equity | $6.7M | $5.7M | $3.4M | $2.3M | $4.3M | $258.5K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology